Niva Bupa Health Insurance Company Ltd
₹ 77.8
1.11%
21 Feb
- close price
About
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
Key Points
- Market Cap ₹ 14,205 Cr.
- Current Price ₹ 77.8
- High / Low ₹ 109 / 69.2
- Stock P/E 174
- Book Value ₹ 11.3
- Dividend Yield 0.00 %
- ROCE 4.85 %
- ROE 5.69 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 6.89 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of -3.86% over last 3 years.
- Earnings include an other income of Rs.329 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 1,057 | 1,413 | 2,114 | 3,165 | 4,196 | |
| 1,094 | 1,435 | 2,374 | 3,534 | 4,413 | |
| Operating Profit | -37 | -22 | -260 | -369 | -217 |
| OPM % | -3% | -2% | -12% | -12% | -5% |
| 0 | 0 | 90 | 413 | 329 | |
| Interest | 4 | 6 | -0 | -0 | -0 |
| Depreciation | 21 | 22 | 27 | 32 | 29 |
| Profit before tax | -62 | -50 | -197 | 13 | 82 |
| Tax % | -0% | -0% | -0% | -0% | -0% |
| -62 | -50 | -197 | 13 | 82 | |
| EPS in Rs | |||||
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 44% |
| TTM: | 33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 54% |
| TTM: | 553% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -4% |
| Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,718 |
| Reserves | -780 | -773 | -903 | -683 | 351 | 344 |
| -0 | -0 | 250 | 250 | 250 | 250 | |
| 891 | 1,322 | 1,983 | 2,799 | 3,891 | 4,840 | |
| Total Liabilities | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 7,151 |
| 39 | 46 | 49 | 52 | 58 | -0 | |
| CWIP | 2 | 2 | 1 | 4 | 1 | -0 |
| Investments | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 5,965 |
| 129 | 230 | 287 | 455 | 675 | 1,186 | |
| Total Assets | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 7,151 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 257 | 338 | 593 | 813 | ||
| -374 | -723 | -829 | -1,882 | ||
| 280 | 374 | 280 | 1,110 | ||
| Net Cash Flow | 164 | -12 | 43 | 41 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | -0 | -0 | -0 | -0 | -0 |
| Inventory Days | |||||
| Days Payable | |||||
| Cash Conversion Cycle | -0 | -0 | -0 | -0 | -0 |
| Working Capital Days | -270 | -290 | -303 | -282 | -292 |
| ROCE % | -10% | -30% | 1% | 5% |
Documents
Announcements
-
Reporting Cyber Threat
1d - Reporting cyber threat and customer data risk.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
13 Feb - Approval for acquisition of 9.7 crore equity shares.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Feb - Schedule of analyst/institutional investor meet on February 20, 2025.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
10 Feb - Transcript of Q3 FY '25 Earnings call released.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
6 Feb - Submission of copies of Newspaper publication of Un-audited financial results for the quarter and nine months ended December 31, 2024
Concalls
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
Leading Insurance Company[1] Niva Bupa is the 3rd largest and the 2nd fastest growing standalone health insurer (SAHI) in India based on overall health gross direct premium income (GDPI) of Rs 5,494.43 crore in FY24 with an overall market share of 5.1%.